Resmetirom: An Update on Therapy for Metabolic Dysfunction-Associated Steatohepatitis (MASH).
Saved in:
| Title: | Resmetirom: An Update on Therapy for Metabolic Dysfunction-Associated Steatohepatitis (MASH). |
|---|---|
| Authors: | Van Kleef LA; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands., Michel M; Department of Internal Medicine II, University Medical Center Saarland, Homburg, Germany.; Medical Faculty, Saarland University, Saarbrücken, Germany., Alkhouri N; Department of Hepatology, Arizona Liver Health, Chandler, AZ, USA., Brouwer WP; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands., Schattenberg JM; Department of Internal Medicine II, University Medical Center Saarland, Homburg, Germany.; Medical Faculty, Saarland University, Saarbrücken, Germany. |
| Source: | Drug design, development and therapy [Drug Des Devel Ther] 2026 Mar 17; Vol. 20, pp. 559331. Date of Electronic Publication: 2026 Mar 17 (Print Publication: 2026). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN: 1177-8881 (Electronic) Linking ISSN: 11778881 NLM ISO Abbreviation: Drug Des Devel Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
